IQVIA Holdings Inc. (IQV)
| Previous close | 240.84 |
| Open | 239.32 |
| Bid | 233.11 x 900 |
| Ask | 233.51 x 900 |
| Day's range | 232.72 - 239.89 |
| 52-week range | 167.42 - 261.73 |
| Volume | |
| Avg. volume | 955,048 |
| Market cap | 42.451B |
| Beta (5Y monthly) | 1.52 |
| PE ratio (TTM) | 31.95 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
RESEARCH TRIANGLE PARK, N.C., April 23, 2024--IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.
- Business Wire
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
RESEARCH TRIANGLE PARK, N.C., April 15, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
- Business Wire
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA, April 08, 2024--IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce (NYSE:CRM), the #1 AI CRM, today announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.
